Genable

About Constantiam Bio

Constantiam Biosciences is a private, pre-revenue biotech founded in 2020 and based in Cambridge, USA. It has developed a core technology platform integrating massively multiplexed functional assays with human genetic data and Bayesian machine learning to generate functional evidence for genetic variants. The company's primary focus is on serving the rare disease and oncology markets by providing tools and insights for VUS resolution, target discovery, and clinical trial optimization through its RareScan, Genable, StratiVar, and MAVEvidence platforms.

Therapeutic Areas